Reduction in the risk of MACE with apabetalone in patients with recent acute coronary syndrome and diabetes according to NAFLD fibrosis score: exploratory analysis of the BETonMACE trial
27 August 2021 (00:00 - 00:00)
Organised by:
About the speaker
CGH Medical Center and The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore (United States of America)
224 More presentations in this session
Doctor B. Keskin Meric (London, GB)
Doctor R. Ong (Makati, PH)
Mr R. Gascuena (Leganes, ES)
Access the full session
The Event
ESC Congress 2021 - The Digital Experience
27 August - 30 August 2021
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation
